First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation

Thoracic and Cardiovascular Surgeon

Volumn 52, Issue 3, 2004, Pages 163-168

  Trosch F ^a   Rothenburger, M ^a   Schneider, M ^a   Welp, H ^a   Etz, C ^a   Wilhelm, M J ^a   Scheld, H H ^a   Schmid, Christof ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Heart transplantation; Immunosuppression; Kidney failure; Rapamycin

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACNE; ADULT; AGED; ANEMIA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFECT; EDEMA; EPISTAXIS; FEMALE; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; MALE; NEUTROPENIA; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RASH; SIDE EFFECT; THROMBOCYTE DISORDER;

AGED; CREATININE; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 3042680078     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-820880     Document Type: Article

References (11)

1. Hertz M, Taylor D, Trulock E et al. The registry of the International Society for Heart and Lung Transplantation: nineteenth official report - 2002. J Heart Lung Transplant 2002; 21: 950-970
2. Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22 989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antiobiot (Tokyo) 1975; 28: 727-732
3. Schmid C, Heemann U, Azuma H, Tilney NL. Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts. Transplantation 1995; 60: 729-733
4. Taylor PJ, Johnson AG. Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid chromatography-electrospary tandem mass spectrometry. J Chromatography B 1998; 721: 285-294
5. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089-1100
6. Healy E, Dempsey M, Lally C, Ryan MP. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int 1998; 54: 1955-1966
7. Groth CG, Backman L, Morales JM et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 1999; 67: 937-938
8. Johnson RWG, Kreis H, Oberbauer R, Brattstrom C, Claesson K, Eris J. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 2001; 72: 777-786
9. Johnson RW. Sirolimus (Rapamune) in renal transplantation. Curr Opin Nephrol Hypertens 2002; 11: 603-607
10. Snell GI, Levvey BJ, Chin W et al. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 2002; 21: 540-546
11. Hariharan S et al. Pharmacokinetics (PK) and tolerability of tacrolimus and sirolimus combination therapy in stable renal transplant recipients. Am J Transplant 2001; 1 (Suppl 1): 406